DD vs LAB
Dupont De Nemours Inc (DD) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. LAB currently screens at market cap $317.1M.
Not investment advice. Open the DD and LAB stock pages for the full models.
Not investment advice.